Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
01/16/2026 | CALL | $190.00 | 1,246 | +341 | +37.68% |
01/16/2026 | PUT | $190.00 | 1,397 | +277 | +24.73% |
11/21/2025 | CALL | $210.00 | 1,661 | +269 | +19.32% |
09/19/2025 | CALL | $190.00 | 1,062 | +267 | +33.58% |
06/20/2025 | CALL | $197.50 | 915 | +175 | +23.65% |
06/27/2025 | CALL | $197.50 | 208 | +174 | +511.76% |
06/20/2025 | PUT | $195.00 | 3,238 | -21 | -0.64% |
08/15/2025 | PUT | $170.00 | 2,331 | -25 | -1.06% |
11/21/2025 | CALL | $200.00 | 1,417 | -25 | -1.73% |
01/16/2026 | CALL | $210.00 | 5,403 | -44 | -0.81% |
06/20/2025 | CALL | $190.00 | 3,980 | -177 | -4.26% |
06/20/2025 | CALL | $200.00 | 8,481 | -199 | -2.29% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.05% | 53.76M | 7.26B |
Vanguard 500 Index Fund | 2.32% | 40.88M | 5.52B |
Fidelity 500 Index Fund | 1.10% | 19.39M | 2.62B |
SPDR S&P 500 ETF Trust | 1.09% | 19.15M | 2.58B |
American Mutual Fund Inc | 1.00% | 17.6M | 2.38B |
iShares Core S&P 500 ETF | 0.89% | 15.78M | 2.13B |
Vanguard Index-Value Index Fund | 0.87% | 15.28M | 2.06B |
Capital Income Builder, Inc. | 0.84% | 14.87M | 2.01B |
Select Sector SPDR Fund-Health Care | 0.81% | 14.36M | 1.94B |
Washington Mutual Investors Fund | 0.75% | 13.22M | 1.78B |
Giant-Cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight
06/12 01:00 pm
GlobeNewswire Inc.
Read moreFDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)
06/11 05:07 pm
Benzinga
Read moreRheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies
06/10 04:53 am
GlobeNewswire Inc.
Read moreCEREVEL ALERT: Bragar Eagel & Squire, P.C. is Investigating Cerevel Therapeutics Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
06/04 09:00 pm
GlobeNewswire Inc.
Read moreContact The Gross Law Firm by June 3, 2025 Deadline to Join Class Action Against Cerevel Therapeutics Holdings, Inc. (ABBV)
06/04 01:00 pm
GlobeNewswire Inc.
Read moreMeta, JPMorgan, Gap And A Health Care Stock On CNBC's 'Final Trades'
06/02 08:21 am
Benzinga
Read moreDrug Device Combination Products Market Analysis Report 2025-2030: Discover the Latest Advances and Opportunities
05/29 05:42 am
GlobeNewswire Inc.
Read moreCERE DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE
05/28 03:27 pm
GlobeNewswire Inc.
Read moreAbbVie To Present Cancer Trial Data At Upcoming ASCO Event
05/27 11:21 am
Benzinga
Read morePrurigo Nodularis Market - Global and Regional Analysis and Forecasts 2025-2035 | Advancements in Biologic Therapies Revolutionize Prurigo Nodularis Treatment
05/26 10:53 am
GlobeNewswire Inc.
Read moreCERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE
05/25 06:32 pm
GlobeNewswire Inc.
Read moreU.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
05/24 04:11 am
The Motley Fool
Read moreCerevel Therapeutics Holdings, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 3, 2025 Deadline to file Lead Plaintiff Motion
05/19 05:59 pm
GlobeNewswire Inc.
Read moreDon't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
05/18 12:05 pm
The Motley Fool
Read moreBlood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight
05/12 01:00 pm
GlobeNewswire Inc.
Read moreContract Research and Manufacturing Services (CRAMS) Business Report 2025: Market to Reach $211.4 Billion by 2030, Fueled by Growing Demand for Biologics and Biosimilars
05/08 10:55 am
GlobeNewswire Inc.
Read moreGeneric Oncology Drugs Market Size Estimated to Reach USD 30,998 Mn by 2034, Rising Global Cancer Cases Increase Demand for Affordable Treatments
05/07 11:00 am
GlobeNewswire Inc.
Read moreCerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights – ABBV
05/05 01:53 pm
GlobeNewswire Inc.
Read moreIs the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
05/04 04:49 am
The Motley Fool
Read moreInvest in These ETFs to Prepare Your Portfolio for a Recession
05/03 08:37 am
The Motley Fool
Read more3 Dividend Stocks to Buy and Hold for the Next Decade
04/28 07:47 am
The Motley Fool
Read moreShould Investors Be Worried About Dividend King AbbVie?
04/28 04:42 am
The Motley Fool
Read more4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
04/26 06:05 pm
The Motley Fool
Read moreWhy AbbVie Stock Topped the Market Today
04/25 05:17 pm
The Motley Fool
Read moreWhy Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
04/22 05:37 pm
The Motley Fool
Read moreIs AbbVie Stock a Buy?
04/20 08:15 am
The Motley Fool
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
04/18 05:12 pm
GlobeNewswire Inc.
Read moreAtopic Dermatitis Drugs Market Forecast 2025-2034 | Rising Drug Approvals and Clinical Trial Successes Propel Revenue Growth, Making Atopic Dermatitis a High-Growth Market
04/18 04:26 am
GlobeNewswire Inc.
Read moreROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
04/14 05:33 pm
GlobeNewswire Inc.
Read moreMale Hypogonadism Market Forecast Report and Company Analysis 2025-2034 Featuring AbbVie, Bayer, Eli Lilly, Endo, Ferring, Perrigo, Pfizer, Sanofi, Teva, and Viatris
04/10 10:00 am
GlobeNewswire Inc.
Read moreBiopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline
04/10 05:59 am
GlobeNewswire Inc.
Read more2 Top Dividend Stocks That Could Set You Up for Life
04/09 07:00 am
The Motley Fool
Read moreDr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far.
04/09 05:44 am
The Motley Fool
Read moreOphthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities
04/08 04:52 am
GlobeNewswire Inc.
Read moreGlobal Cosmeceuticals Market Size to Reach USD 182.17 Bn by 2032, at a CAGR of 9.6%, says Coherent Market Insights
04/08 12:50 am
GlobeNewswire Inc.
Read more3 Dividend Stocks to Buy and Hold for the Next Decade
04/06 06:44 am
The Motley Fool
Read more2 Dividend Stocks to Buy Hand Over Fist in April
04/05 08:30 am
The Motley Fool
Read moreTrump's Tariff Exemptions Include Semiconductors, Pharmaceuticals, Oil And More
04/03 12:30 pm
Benzinga
Read morePersonalized Medicine Market Growth Trends 2025-2033: Transition to Customized Medical Care, Developments in Bioinformatics and Genomics, Growing Prevalence of Chronic Diseases
04/02 04:52 am
GlobeNewswire Inc.
Read moreWant $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
03/31 04:53 am
The Motley Fool
Read moreGlobal Autoimmune Disease Therapeutics Market to reach USD 226,194.0 Million by 2035 Amid Rising Prevalence and Advancements in Biologic Therapies | Future Market Insights, Inc.
03/23 08:30 pm
GlobeNewswire Inc.
Read moreGenmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.
03/21 11:29 pm
GlobeNewswire Inc.
Read moreAbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients
03/17 02:02 pm
Benzinga
Read more5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond
03/17 07:45 am
The Motley Fool
Read more1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction
03/16 06:19 pm
The Motley Fool
Read more3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
03/14 05:51 am
The Motley Fool
Read moreComplement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - Global Forecast to 2030
03/12 11:50 am
GlobeNewswire Inc.
Read moreXilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results
03/11 07:30 am
GlobeNewswire Inc.
Read moreMixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas
03/10 04:53 pm
The Motley Fool
Read more